This amount was spread across over 669 programs among 253 different manufacturers - a 48% increase since 2016. Copay assistance dollars for commercially insured plans tripled from $6 to $18 billion just between 20. 3Ĭopay assistance programs are a significant and growing presence in the specialty drug world. Researchers from Harvard, Kellogg and ULCA business schools calculate that consumers pay up to $2.7 billion more for health care because of copay assistance. Overall, individual consumers wind up paying more, not less. Those increased costs are passed along to members in the form of higher premiums. Unfortunately, when coupon programs drive increased sales of high-priced drugs, employers and insurers must pay for them. One study found that for every $1 million invested in coupons, pharmaceutical manufacturers realized more than $20 million in profits. 1Īs tools, coupons are extremely effective. This may circumvent plan sponsors' formulary strategy, as the presence of a copay card means patients may not have financial incentive to utilize a lower-cost preferred therapy. Drug manufacturers use them to steer insured patients toward their medication. Ĭopay coupons, at their core, are a marketing tool. Manufacturer copay assistance programs help insured patients afford expensive prescription drugs by covering part or all of a member’s deductible and copay for certain medications. Drug maker copay cards can disrupt your benefit strategy unless you act.Īs drug costs continue to rise, drug manufacturers have designed ways to reduce the out-of-pocket costs for patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |